Tokyo, Japan

Kei Yamana

This inventor holds 2 USPTO granted patents. Top assignee: Teijin Pharma Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kei Yamana. Retrieved from https://idiyas.com/inventor/kei-yamana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kei Yamana: Innovator in Protein Research

Introduction

Kei Yamana is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of protein research, particularly in the development of novel polypeptides with therapeutic applications. With a total of 2 patents, his work is paving the way for advancements in medical treatments.

Latest Patents

Yamana's latest patents focus on a protein and its production process, which aims to provide a polypeptide with a unique structure. This polypeptide exhibits activities that inhibit angiogenesis and osteoclastogenesis. The recombinant protein developed through his research is intended to be useful in designing remedies for various conditions, including tendinitis, rheumatoid arthritis, arthritis deformans, and malignant tumors. His innovative approach involves constructing a method for purifying this novel soluble polypeptide protein.

Career Highlights

Kei Yamana is currently employed at Teijin Pharma Limited, where he continues to advance his research in protein science. His work has garnered attention for its potential impact on therapeutic solutions in the medical field.

Collaborations

Yamana collaborates with notable colleagues, including Yasunori Nakayama and Yoshimasa Takahashi. Their combined expertise contributes to the innovative research being conducted at Teijin Pharma Limited.

Conclusion

Kei Yamana's contributions to protein research and his innovative patents highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also holds promise for developing effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…